A study investigating the treatment of equine squamous gastric disease with long‐acting injectable or oral omeprazole
Abstract Background Equine squamous gastric disease (ESGD) is a highly prevalent disease in horses, particularly in elite athletes. Some horses respond slowly, or fail to respond, to the licensed treatment, oral omeprazole (ORLO). Objectives To compare rates of ESGD healing and improvement between O...
Main Authors: | Sarah Gough, Gayle Hallowell, David Rendle |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-05-01
|
Series: | Veterinary Medicine and Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/vms3.220 |
Similar Items
-
Evaluation of the treatment of equine glandular gastric disease with either long‐acting‐injectable or oral omeprazole
by: Sarah Gough, et al.
Published: (2022-03-01) -
Therapeutic efficacy of “Omeprazole” in horses with equine gastric ulcer syndrome
by: O. Stefanyk, et al.
Published: (2022-07-01) -
Gastric Corpus Hypertrophy with a Bleeding Hyperplastic Polyp in a -naive Subject after Long-term Proton Pump Inhibitor Use
by: Jong Hyeon Jeong, et al.
Published: (2022-03-01) -
Evaluation of a long‐acting injectable formulation of omeprazole in healthy dogs
by: Adesola Odunayo, et al.
Published: (2022-07-01) -
EARLY PARENTERAL USE OF PROTON PUMP INHIBITORS IN THE COMPLEx TREATMENT OF ACUTE POISONING WITH CAUTERANT AGENTS
by: K. K. Ilyashenko, et al.
Published: (2016-03-01)